WUSA9 | April 8, 2022
“It’s been far too long since Novavax has asked for authorization and I think the FDA has been slow-walking it,” said Lawrence Gostin, a Professor of Global Health Law at Georgetown University.
WUSA9 | April 8, 2022
“It’s been far too long since Novavax has asked for authorization and I think the FDA has been slow-walking it,” said Lawrence Gostin, a Professor of Global Health Law at Georgetown University.
In The News
July 24, 2024
Press Release
July 24, 2024
In The News
July 23, 2024